Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Blood Coagulation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT06452342
What this trial is testing

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study

Who this might be right for
Venous ThromboembolismVenous ThrombosesHeavy Menstrual Bleeding+1 more
University Health Network, Toronto 20
Not applicableStudy completedNCT04074980
What this trial is testing

Evaluating LumiraDx INR Test Accuracy in Patients Taking Phenprocoumon Anticoagulant.

Who this might be right for
Anticoagulants and Bleeding Disorders
LumiraDx UK Limited 102
Testing effectiveness (Phase 2)Study completedNCT00496262
What this trial is testing

Human Fibrinogen - Pharmacokinetics

Who this might be right for
Fibrinogen Deficiency
CSL Behring 15
Not applicableStudy completedNCT05699980
What this trial is testing

Prevalence and Comorbidities of Dermatoporosis: a French Prospective Observational Study in General Medicine Consultation

Who this might be right for
Dermatoporosis
University of Lorraine 370
Not applicableStudy completedNCT02457403
What this trial is testing

Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy

Who this might be right for
CirrhosisCoagulopathy
Ohio State University 68
Large-scale testing (Phase 3)Active Not RecruitingNCT07216079
What this trial is testing

Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan

Who this might be right for
Immune Thrombocytopenia
Sanofi 4
Not applicableEnded earlyNCT02569359
What this trial is testing

Efficacy and Safety of Shea Nut Oil in Hemophilic Arthropathy

Who this might be right for
HemophiliaHemophilic Arthropathy
Tri-Service General Hospital (TSGH) 6
Large-scale testing (Phase 3)Study completedNCT02250573
What this trial is testing

An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

Who this might be right for
Haemophilia B
Bio Products Laboratory
Early research (Phase 1)UnknownNCT02888223
What this trial is testing

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

Who this might be right for
Hemophilia A
Sinocelltech Ltd. 16
Not applicableLooking for participantsNCT04728841
What this trial is testing

Gene Therapy for Chinese Hemophilia A

Who this might be right for
Hemophilia AGene Therapy
Institute of Hematology & Blood Diseases Hospital, China 12
Large-scale testing (Phase 3)WithdrawnNCT00233246
What this trial is testing

Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures

Who this might be right for
Blood Coagulation Disorders
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Post-approval studies (Phase 4)Study completedNCT00188747
What this trial is testing

Comparison of Three Management Strategies for Post Cardiac Surgery Bleeding

Who this might be right for
Heart DiseaseCoagulopathy
University Health Network, Toronto 150
Not applicableUnknownNCT05785468
What this trial is testing

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1
Not applicableWithdrawnNCT01422343
What this trial is testing

Microparticles and the Risk of Re-stenosis Following Balloon Angioplasty in Patients With Peripheral Arterial Disease

Who this might be right for
Peripheral Vascular Diseases
Insel Gruppe AG, University Hospital Bern
Large-scale testing (Phase 3)UnknownNCT05487976
What this trial is testing

Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor

Who this might be right for
Hemophilia AHemophilia B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Not applicableStudy completedNCT05486338
What this trial is testing

Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy

Who this might be right for
ObesityAdiposity
Erbe Elektromedizin GmbH 15
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208
Post-approval studies (Phase 4)UnknownNCT04102033
What this trial is testing

Eltrombopag in Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Assiut University 20
Large-scale testing (Phase 3)Study completedNCT04158648
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Who this might be right for
Mild Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHemophilia A
Hoffmann-La Roche 73
Next Page